Anavex Life Sciences Corp (AVXL)

[gburgin]

The problem with the question is it assumes the results are either good or garbage. What about results that just lack clarity? People have pointed out how as the updates progressed, previously given detail was dropped (e.g. dose dependency). What if the latest results are not showing dose dependency and that is why no update has been given, and that has lead to this selloff? Would that apparent lack of dose dependency be what you would consider "garbage" results that would send big names fleeing from the BOD? I would think they are much more science focused than results focused regarding a small n trial.